Zhuhai Rundu Pharmaceutical Co., Ltd.

SZSE:002923.SZ

12.55 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32015 Q22015 Q1
Revenue 277.34291.072306.094346.522289.928296.078359.359380.255333.113336.147322.719327.431287.967250.431324.097294.3303.163337.412317.755340.829328.324350.052340.703293.323273.545254.82222.172219.833186.716186.989185.884177.571168.574140.696140.696
Cost of Revenue 163.706152.679153.972174.515148.101131.651184.496159.89154.449148.679137.771124.626116.44988.708129.053117.665115.136112.976115.107100.57689.65493.17596.55966.57962.26264.32467.09961.56572.09162.62179.38164.18563.02843.90443.904
Gross Profit 113.634138.394152.122172.008141.827164.427174.863220.365178.664187.468184.948202.806171.518161.723195.044176.635188.027224.436202.648240.253238.67256.876244.145226.744211.283190.496155.074158.267114.624124.367106.503113.386105.54696.79296.792
Gross Profit Ratio 0.410.4750.4970.4960.4890.5550.4870.580.5360.5580.5730.6190.5960.6460.6020.60.620.6650.6380.7050.7270.7340.7170.7730.7720.7480.6980.720.6140.6650.5730.6390.6260.6880.688
Reseach & Development Expenses 37.77434.87124.95451.64434.4123.33520.05433.33518.73321.90721.61531.16521.3420.80718.82831.17322.7824.42324.0933.8322.97522.97334.76324.17519.36534.30310.66244.693016.5340004.0024.002
General & Administrative Expenses 0-6.59319.267-29.70445.168-0.49215.404-25.89940.744-3.50712.261-43.38146.597-3.71915.743-14.53123.6260.08519.603-8.58125.6838.17510.766-56.71832.194-10.80628.873-23.10317.396-9.55417.3060011.21611.216
Selling & Marketing Expenses 063.32969.22758.46887.30485.74383.11475.58101.341103.436109.195106.05898.40993.405118.78285.982103.409130.26121.338169.472153.942173.115165.04177.629146.463138.337101.338102.68269.23573.04666.980062.33162.331
SG&A 80.57556.73688.49328.764132.47285.25198.51849.681142.08599.929121.45662.677145.00689.686134.52571.452127.035130.346140.941160.891179.625181.29175.806120.911178.657127.531130.21125.79786.63163.49284.2860073.54673.546
Other Expenses -0.773-0.046-0.2-0.366-0.287-0.153-0.00643.952-20.87821.1920.029-0.091-1.704-0.122-0.131-3.433-0.978-0.137-0.202-0.571-0.159-0.212-0.1690.0731.036-0.195-1.04-4.290.162-1.0184.034-92.592-82.38300
Operating Expenses 119.122114.011112.975126.56143.542122.613118.566126.968139.941143.028143.1143.374142.904131.89153.141142.439147.293177.819164.709221.716200.716217.726210.232206.253179.172158.434130.454127.22788.97287.87586.525-92.592-82.38374.98974.989
Operating Income -5.48810.83333.7287.124-4.71536.13747.72165.26931.86342.64541.57854.02529.33430.33340.09328.73938.95549.07336.81519.06140.4641.89432.13725.35933.18135.65725.64529.41423.04534.45617.04920.79423.16221.321.3
Operating Income Ratio -0.020.0370.110.021-0.0160.1220.1330.1720.0960.1270.1290.1650.1020.1210.1240.0980.1280.1450.1160.0560.1230.120.0940.0860.1210.140.1150.1340.1230.1840.0920.1170.1370.1510.151
Total Other Income Expenses Net 2.232-0.046-6.276-59.835-0.287-0.1530.579-0.036-0.294-0.2540.17-0.091-0.9840.378-1.941-8.89-2.7582.319-1.326-0.0472.3482.532-1.9454.9412.1053.4-0.015257.456-91.418-4.0941.105234.9-79.840.2270.227
Income Before Tax -3.25710.78733.5286.758-5.00235.98448.365.23331.56842.39141.74853.93427.6330.21139.96225.30537.97748.93636.61318.4940.30141.68231.96825.43234.21735.46224.60525.12423.20632.39821.08321.38225.70621.52721.527
Income Before Tax Ratio -0.0120.0370.110.02-0.0170.1220.1340.1720.0950.1260.1290.1650.0960.1210.1230.0860.1250.1450.1150.0540.1230.1190.0940.0870.1250.1390.1110.1140.1240.1730.1130.120.1520.1530.153
Income Tax Expense -2.6362.0424.4725.418-1.3087.1647.86811.3795.045.423.6242.7613.6190.6724.9180.293.4954.5434.641-1.8237.0365.3512.981-0.5545.5393.2424.6453.0610.8924.5462.66236.849-78.7993.2313.231
Net Income -0.6218.74629.0561.341-3.69428.8240.43253.85426.52836.97138.12451.17324.01129.53935.04425.01634.48244.39331.97220.31333.26536.33228.98725.98628.67832.2219.9622.06322.31427.85218.42318.84522.12118.29618.296
Net Income Ratio -0.0020.030.0950.004-0.0130.0970.1130.1420.080.110.1180.1560.0830.1180.1080.0850.1140.1320.1010.060.1010.1040.0850.0890.1050.1260.090.10.120.1490.0990.1060.1310.130.13
EPS -0.0020.090.090.004-0.0110.0860.120.160.150.20.160.150.130.160.10.140.10.250.0990.110.0990.20.0880.140.0880.20.0810.150.0840.210.0760.140.090.0750.075
EPS Diluted -0.0020.090.090.004-0.0110.0860.120.160.150.20.160.150.130.160.10.140.10.250.0990.110.0990.20.0880.140.0880.20.0810.150.0840.210.0760.140.090.0750.075
EBITDA 0.56825.00139.96544.651-1.91544.21257.20692.60438.52846.64942.53959.38226.87529.20542.40230.12338.52448.87339.00319.04440.2142.54236.21332.12533.36937.56822.497-238.569114.62437.14921.359-198.517105.54621.58521.585
EBITDA Ratio 0.0020.0860.1310.129-0.0070.1490.1590.2440.1160.1390.1320.1810.0930.1170.1310.1020.1270.1450.1230.0560.1220.1220.1060.110.1220.1470.101-1.0850.6140.1990.115-1.1180.6260.1530.153